The use of higher platelet: Rbc transfusion ratio in the acute phase of trauma resuscitation: A systematic review*

Critical Care Medicine

Volumn 41, Issue 12, 2013, Pages 2800-2811

  Hallet, Julie ^a,b   Lauzier, François ^a,b   Mailloux, Olivier ^b   Trottier, Vincent ^a,b   Archambault, Patrick ^a,b   Zarychanski, Ryan ^c,d   Turgeon, Alexis F ^a,b  

^a Université Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CancerCare Manitoba ^*  (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Blood platelets; Blood transfusion; Massive transfusion; Mortality; Trauma hemorrhage; Wounds and injuries

Indexed keywords

HEMOGLOBIN; HEMOSTATIC AGENT;

APHERESIS; BIBLIOGRAPHIC DATABASE; BIOSIS; BLEEDING; COCHRANE LIBRARY; CONSERVATIVE TREATMENT; DATA EXTRACTION; EMBASE; ERYTHROCYTE TRANSFUSION; HUMAN; INJURY SCALE; LUNG INJURY; MEDLINE; META ANALYSIS; MORTALITY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK ASSESSMENT; SCOPUS; SEPSIS; SURVIVAL; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; WEB OF SCIENCE;

EID: 84889239806     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31829a6ecb     Document Type: Review

References (66)

1. Copes WS, Champion HR, Sacco WJ, et al. Progress in characterizing anatomic injury. J Trauma 1990; 30:1200-1207 (Pubitemid 20372833)
2. Cothren CC, Moore EE, Hedegaard HB, et al. Epidemiology of urban trauma deaths: A comprehensive reassessment 10 years later. World J Surg 2007; 31:1507-1511 (Pubitemid 46945377)
3. Baker SP, O'Neill B, Haddon W Jr, et al. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14:187-196
4. Stewart RM, Myers JG, Dent DL, et al. Seven hundred fifty-three consecutive deaths in a level I trauma center: The argument for injury prevention. J Trauma 2003; 54:66-70
5. Holcomb JB, Zarzabal LA, Michalek JE, et al. Trauma Outcomes Group: Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011; 71:S318-S328
6. Inaba K, Lustenberger T, Rhee P, et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 2010; 211:573-579
7. Shaz BH, Dente CJ, Nicholas J, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010; 50:493-500
8. Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998; 186:528-533 (Pubitemid 28222075)
9. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma 2003; 54:1127-1130 (Pubitemid 36764882)
10. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: A review of mechanisms. J Trauma 2008; 65:748-754
11. Perkins JG, Cap AP, Andrew CP, et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009; 66:S77-84
12. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63:805-813 (Pubitemid 350287298)
13. Maegele M, Lefering R, Paffrath T, et al. Working Group on Polytrauma of the German Society of Trauma Surgery (DGU): Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: A retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Vox Sang 2008; 95:112-119 (Pubitemid 351951900)
14. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248:447-458
15. Duchesne JC, Hunt JP, Wahl G, et al. Review of current blood transfusions strategies in a mature level I trauma center: Were we wrong for the last 60 years? J Trauma 2008; 65:272-276
16. Sambasivan CN, Kunio NR, Nair PV, et al. Trauma Outcomes Group: High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients. J Trauma 2011; 71:S329-S336
17. Scalea TM, Bochicchio KM, Lumpkins K, et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 2008; 248:578-584
18. Dzik WH, Blajchman MA, Fergusson D, et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products-Massive transfusion consensus conference 2011: Report of the panel. Crit Care 2011; 15:242
19. Curry N, Hopewell S, Dorée C, et al. The acute management of trauma hemorrhage: A systematic review of randomized controlled trials. Crit Care 2011; 15:R92
20. Phan HH, Wisner DH: Should we increase the ratio of plasma/platelets to red blood cells in massive transfusion: What is the evidence? Vox Sang 2010; 98:395-402
21. Higgins J, Green S (Eds): Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Book Series. West Sussex, England: Wiley-Blackwell, 2008
22. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
23. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
24. Jüni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282:1054-1060 (Pubitemid 29436453)
25. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.lri.ca/ programs/ceu/oxford.htm. Accessed August 16, 2012
26. von Elm E, Altman DG, Egger M, et al. STROBE Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007; 370:1453-1457
27. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012 (Pubitemid 30214957)
28. Zhou Z, Rahme E, Abrahamowicz M, et al. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: A comparison of methods. Am J Epidemiol 2005; 162:1016-1023 (Pubitemid 41619473)
29. Ho AM, Dion PW, Yeung JH, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology 2012; 116:716-728
30. Cotton BA, Gunter OL, Isbell J, et al. Damage control hematology: The impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008; 64:1177-1182 (Pubitemid 351671208)
31. Dirks J, Jørgensen H, Jensen CH, et al. Blood product ratio in acute traumatic coagulopathy-effect on mortality in a Scandinavian level 1 trauma centre. Scand J Trauma Resusc Emerg Med 2010; 18:65
32. Curry N, Stanworth S, Hopewell S, et al. Trauma-induced coagulopathy-a review of the systematic reviews: Is there sufficient evidence to guide clinical transfusion practice? Transfus Med Rev 2011; 25:217-231.e2
33. Zink KA, Sambasivan CN, Holcomb JB, et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009; 197:565-570
34. Tholpady A, Cotton B, Hobbs R, et al. Blood utilization during and after massive transfusion. Transfusion 2011; 51(Supp):179A
35. Cotton BA, Reddy N, Hatch QM, et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg 2011; 254:598-605
36. Cotton BA, Au BK, Nunez TC, et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009; 66:41-48
37. Rowell SE, Barbosa RR, Diggs BS, et al. Trauma Outcomes Group: Effect of high product ratio massive transfusion on mortality in blunt and penetrating trauma patients. J Trauma 2011; 71:S353-S357
38. Chambers LA, Chow SJ, Shaffer LE: Frequency and characteristics of coagulopathy in trauma patients treated with a low-or highplasma-content massive transfusion protocol. Am J Clin Pathol 2011; 136:364-370
39. Van PY, Sambasivan CN, Wade CE, et al. High transfusion ratios are not associated with increased complication rates in patients with severe extremity injuries. J Trauma 2010; 69(Suppl 1):S64-S68
40. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 2009; 66:1616-1624
41. Rose AH, Kotzé A, Doolan D, et al. Massive transfusion-evaluation of current clinical practice and outcome in two large teaching hospital trusts in Northern England. Vox Sang 2009; 97:247-253
42. Gunter OL Jr, Au BK, Isbell JM, et al. Optimizing outcomes in damage control resuscitation: Identifying blood product ratios associated with improved survival. J Trauma 2008; 65:527-534
43. Bochicchio GV, Napolitano L, Joshi M, et al. Outcome analysis of blood product transfusion in trauma patients: A prospective, riskadjusted study. World J Surg 2008; 32:2185-2189
44. Fuller G, Bouamra O, Woodford M, et al. Recent massive blood transfusion practice in England and Wales: View from a trauma registry. Emerg Med J 2012; 29:118-123
45. Wade CE, del Junco DJ, Holcomb JB, et al. Trauma Outcomes Group: Variations between level I trauma centers in 24-hour mortality in severely injured patients requiring a massive transfusion. J Trauma 2011; 71:S389-S393
46. Holcomb JB, Wade CE, Brasel KJ, et al. Trauma Outcomes Group: Defining present blood component transfusion practices in trauma patients: Papers from the Trauma Outcomes Group. J Trauma 2011; 71:S315-S317
47. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: Directly addressing the early coagulopathy of trauma. J Trauma 2007; 62:307-310
48. Nunez TC, Young PP, Holcomb JB, et al. Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 2010; 68:1498-1505
49. McLaughlin DF, Niles SE, Salinas J, et al. A predictive model for massive transfusion in combat casualty patients. J Trauma 2008; 64:S57-S63
50. Maegele M, Lefering R, Wafaisade A, et al. Trauma Registry of Deutsche Gesellschaft für Unfallchirurgie (TR-DGU): Revalidation and update of the TASH-Score: A scoring system to predict the probability for massive transfusion as a surrogate for life-threatening haemorrhage after severe injury. Vox Sang 2011; 100:231-238
51. Maegele M, Brockamp T, Nienaber U, et al. Predictive models and algorithms for the need of transfusion including massive transfusion in severely injured patients. Transfus Med Hemother 2012; 39:85-97
52. Spinella PC, Holcomb JB: Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009; 23:231-240
53. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83
54. Kashuk JL, Moore EE, Wohlauer M, et al. Initial experiences with pointof-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. Transfusion 2012; 52:23-33
55. Innerhofer P, Westermann I, Tauber H, et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44:209-216
56. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117:531-547
57. Harr JN, Moore EE, Johnson J, et al. Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients. Crit Care Med 2013; 41:399-404
58. Dutton RP, Parr M, Tortella BJ, et al. CONTROL Study Group: Recombinant activated factor VII safety in trauma patients: Results from the CONTROL trial. J Trauma 2011; 71:12-19
59. Riskin DJ, Tsai TC, Riskin L, et al. Massive transfusion protocols: The role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009; 209:198-205
60. Gerrard JM, Docherty JC, Israels SJ, et al. A reassessment of the bleeding time: Association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time. Clin Invest Med 1989; 12:165-171 (Pubitemid 19144610)
61. Kaibara M, Iwata H, Ujiie H, et al. Rheological analyses of coagulation of blood from different individuals with special reference to procoagulant activity of erythrocytes. Blood Coagul Fibrinolysis 2005; 16:355-363 (Pubitemid 41008743)
62. Hiippala ST, Myllylä GJ, Vahtera EM: Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81:360-365
63. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64:S79-S85
64. American Association of Blood Banks (Ed): Standards for Blood Banks and Transfusion Services. 27th Edition. Bethesda, MD, American Association of Blood Banks, 2011
65. Rossaint R, Bouillon B, Cerny V, et al. Task Force for Advanced Bleeding Care in Trauma: Management of bleeding following major trauma: An updated European guideline. Crit Care 2010; 14:R52
66. Sorensen B, Fries D: Emerging treatment strategies for traumainduced coagulopathy. Br J Surg 2012; 99(Supp):1-12